ZUG, Switzerland and BOSTON, Feb. 11, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical ...

We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Sovereign Wealth Fund. In this ...

Oxford Cannabinoid Technologies is shedding its old skin. Having delisted its stock last year, the biotech is rebranding as ...

For example, Brittany found that drugs being developed by Generate were modified versions of existing antibodies, and that ...

In a report released today, Elyse Shapiro from Canaccord Genuity maintained a Buy rating on Mayne Pharma Group (MAYNF – Research Report), with ...

As a market leader, Rocket Companies rebranding comes in the foreground of several court battles and fluctuating earnings ...

Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame ...

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research led by investigators at the Johns Hopkins Kimmel ...

Drugmakers offer “copay assistance programs” to help people afford expensive medicines. But health insurers are milking these ...

Robert F. Kennedy Jr’s message of eliminating toxins and investigating public health agencies has resonated among a key group ...

OpenAI's rebrand balances the technical and the emotional by updating its logo and centering a new typeface called OpenAI ...